Appointment of Executive Chairman at ADAM

Appointment of Executive Chairman at ADAM Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Professor Steve Myers OBE, Head of Medical Applications at CERN, has been appointed as Executive Chairman of Advanced Oncotherapy's fully owned subsidiary ADAM S.A ("ADAM"). ADAM was founded in 2007 as a spin-off from CERN, the European Organisation for Nuclear Research, and was acquired by Advanced Oncotherapy in 2013. The...

A&T Seminar

19 April 2012 Accelerators and Medicine by Donatella Ungaro  
RSS
12